Anil Kane, Ph.D., MBA, Patheon, Part of Thermo Fisher Scientific - Qepler Summits And Conferences

Anil Kane, Ph.D., MBA

Executive Director, Global Head of Technical & Scientific Affairs Pharma Services
Patheon, Part of Thermo Fisher Scientific
Toronto, Canada
Patheon, Part of Thermo Fisher Scientific - Global Pharma Contract Development & Manufacturing (CDMO)

Dr. Kane has more than 25 years of experience in the science and business of taking molecules through the entire drug development process. His extensive knowledge spans early stage development to scale-up and commercial manufacturing, and includes technical transfers between global sites and drug life cycle management.

Dr. Kane received his Bachelors, Masters and Ph.D. degrees from the University of Bombay, India, and served as a post-doctoral fellow at the School of Pharmacy, University of Cincinnati, Ohio. He has also earned an executive MBA from Richard Ivey School of Business, University of Western Ontario, Canada. Dr. Kane is a member of various international pharmaceutical professional organizations, and is often asked to speak about scientific topics on formulation, technology other technical aspects, QbD, etc at major industry events. He has also published many articles in International journals and delivered many talks at meetings and conferences cross the globe.

In his current role as Executive Director, Dr. Kane supports our clients in developing sound formulation and process development strategies and closely works with the scientific teams at Patheon’s global sites for execution, provides leadership in the complete development of novel lead compounds and line extensions. He is also responsible for evaluating drug delivery technologies to support the business. Dr. Kane has been an invited speaker at many global conferences, workshops, seminars and training programs and has published several articles, interviews and white papers across the world including North American, European, Japanese and Korean publications.

Related Sessions:

Highly Potent APIs
Summit 2019

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 20 Feb 2019
  • Berlin, DE
  • Pharma
Day 2: Thursday, 21 February 2019
CASE STUDY: Development & Manufacturing Considerations of High Potent Drug Products – a CDMO’s perspective.
  • Trends of High Potent API’s and a CDMO view on the future of supporting high potent drug product manufacturing
  • Regulatory considerations in handling special category of compounds in a segregated infrastructure.
  • Case studies and containment solutions in handling potent API’s in drug product manufacturing
  • CDMO view on strategizing supporting high potent API and DP manufacturing support to the pharmaceutical industry
View Details